Mucosal delivery of ESX-1–expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes | Zendy

Harindra D. Sathkumara | Zendy; Visai Muruganandah | Zendy; Martha M. Cooper | Zendy; Matthew A. Field | Zendy; Md Abdul Alim | Zendy; Roland Brosch | Zendy; Natkunam Ketheesan | Zendy; Brenda Govan | Zendy; C. M. Rush | Zendy; Lars Henning | Zendy; Andreas Kupz | Zendy

Open Access

Mucosal delivery of ESX-1–expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes

Author(s) -

Harindra D. Sathkumara,

Visai Muruganandah,

Martha M. Cooper,

Matthew A. Field,

Md Abdul Alim,

Roland Brosch,

Natkunam Ketheesan,

Brenda Govan,

C. M. Rush,

Lars Henning,

Andreas Kupz

Publication year - 2020

Publication title -

proceedings of the national academy of sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.011

H-Index - 771

eISSN - 1091-6490

pISSN - 0027-8424

DOI - 10.1073/pnas.2003235117

Subject(s) - tuberculosis , medicine , mycobacterium tuberculosis , immunity , immunology , vaccination , context (archaeology) , type 2 diabetes , diabetes mellitus , disease , bcg vaccine , immune system , virology , biology , pathology , endocrinology , paleontology

Significance Tuberculosis (TB) susceptibility and disease are significantly exacerbated in people with type 2 diabetes. The underlying mechanisms are incompletely understood, and it is not known if new TB vaccine candidates will be safe and provide protection in the context of diabetes. Using a long-term diet-induced murine model of type 2 diabetes, we demonstrate that increased susceptibility to TB is caused by impaired mycobacterial recognition and killing in the diabetic lung. Importantly, we show that mucosal vaccination of diabetic mice with Bacillus Calmette–Guérin (BCG) strains expressing the ESX-1 secretion system fromMycobacterium tuberculosis can overcome this defect and provide superior immunity against TB. Our data warrant a consideration of ESX-1–containing BCG strains as effective TB vaccines in older individuals and diabetics.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research